The U.S. Food and Drug Administration (FDA) has granted its orphan drug designation to Alentis Therapeutics’ antibody-based therapy lixudebart…
Articles by Mary Chapman
The Pulmonary Fibrosis Foundation (PFF) said its two-year-old patient Community Registry achieved a “significant milestone” in its goal…
Sweden-based Vicore Pharma has granted exclusive rights to pharmaceutical company Nippon Shinyaku to develop and commercialize its treatment candidate…
Five new Pulmonary Fibrosis Foundation (PFF) scholars will each use $100,000, granted over the course of two years, to…
For the 14th year, a cast of Broadway luminaries will take the stage for the Pulmonary Fibrosis Foundation’s (PFF)…
Almee, an investigational app that offers personalized treatment to help people with pulmonary fibrosis (PF), was found to significantly…
The pharmaceutical company Humanetics will use a federal grant to fund a series of studies aimed at advancing the…
Supporters are gearing up to mark Pulmonary Fibrosis Awareness Month, set aside every September, to call attention to the rare…
The Pulmonary Fibrosis Foundation (PFF) is urging patients to use only federally approved oxygen delivery devices, as nonprescription supplemental…
Innovate UK has awarded biotechnology company Senisca £571,350 (about $712,000) to develop oligonucleotide treatments for idiopathic pulmonary…